Suchergebnisse - "Spinner, Christoph D"

PubPharm (224)

101

Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany

enthalten in: Infection | 2021

von Koehler, J. | Ritzer, B. | Weidlich, S. | +10

102

Key summary of German national treatment guidance for hospitalized COVID-19 patients

enthalten in: Infection | 2021

von Malin, J. | Spinner, C. | Janssens, U. | +24

103

Key summary of German national treatment guidance for hospitalized COVID-19 patients

enthalten in: Infection | 2021

von Malin, J. | Spinner, C. | Janssens, U. | +24

104

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma

enthalten in: HemaSphere | 2021

von Gaitzsch, E. | Passerini, V. | Khatamzas, E. | +36

105

Hepatitis C virus : Current steps toward elimination in Germany and barriers to reaching the 2030 goal

enthalten in: Health science reports | 2021

von Sarrazin, C. | Boesecke, C. | Golsabahi-Broclawski, S. | +9

106

Clinical and Ophthalmological Characteristics of Ocular Syphilis in a Retrospective Tertiary Hospital Cohort

enthalten in: Sexually transmitted diseases | 2021

von Wagner, L. | Lanzl, I. | Rothe, K. | +9

107

Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS

enthalten in: Scientific reports | 2021

von Rasch, S. | Schmidle, P. | Sancak, S. | +10

108

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned

enthalten in: Viruses | 2021

von Dölken, L. | Stich, A. | Spinner, C.

109

Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR) : a structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Keitel, V. | Jensen, B. | Feldt, T. | +39

110

Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Keitel, V. | Jensen, B. | Feldt, T. | +23